// App-Quantinova.ai

2611 : A New High Activity Anti-CD22 Chimeric Antigen Receptor (CAR) Targeting B Cell Leukemia.

Researchers

Presenter

  • Daniel W. Lee III

Principal Investigators

  • Ira Pastan

  • Dimiter S. Dimitrov

  • Crystal L Mackall

  • Rimas J Orentas

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Galectin-3

Drug/Treatment

  • CAT-3888

  • Moxetumomab pasudotox

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved